American Journal of Roentgenology, Vol 162, 201-207, Copyright © 1994 by American Roentgen Ray Society

ARTICLES

MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement

R Guimaraes, O Clement, J Bittoun, F Carnot and G Frija
Laboratoire de Recherche en Imagerie, Faculte de Medecine Necker, Paris, France.

OBJECTIVE. The purpose of this study in rodents was to determine the pathologic basis for enhancement patterns of hyperplastic and tumours lymph nodes shown by MR lymphography after IV injection of superparamagnetic iron oxide nanoparticles (AMI-227). MATERIALS AND METHODS. Hyperplastic and tumorous lymph nodes were imaged in vivo at 1.5 T 1 day after IV administration of AMI-227 (40-200 mumol Fe/kg) to rats. Inguinal and axillary lymph nodes were surgically resected, and in vitro imaging was done by using the same magnet with a prototype coil that allowed a pixel size of 70 x 230 microns. Imaging findings were correlated with histologic findings and iron staining of the nodes. RESULTS. With all sequences, at doses of 80 mumol Fe/kg or higher, the signal intensity of hyperplastic nodes was lower than on unenhanced images. The same pattern was seen in the remaining normal tissue of tumourous lymph nodes. This T2* effect was a result of clustered particles inside macrophages in the lymphatic sinuses. At doses of 200 mumol/kg, the tumor itself consistently showed an increase in signal intensity on T1-weighted images. This T1 effect probably resulted from particles leaking into the interstitial spaces of the tumor. CONCLUSION. After IV injection of superparamagnetic nanoparticles, a decrease in signal intensity indicates active uptake of particles into macrophages, whereas an increase in signal intensity indicates altered capillary permeability in tumor. These findings in rats may prove to be clinically useful in the future for differentiating benign from malignant enlarged lymph nodes.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. G. Harisinghani, M. A. Saksena, P. F. Hahn, B. King, J. Kim, M. T. Torabi, and R. Weissleder Ferumoxtran-10-Enhanced MR Lymphangiography: Does Contrast-Enhanced Imaging Alone Suffice for Accurate Lymph Node Characterization? Am. J. Roentgenol., January 1, 2006; 186(1): 144 - 148. [Abstract] [Full Text] [PDF]

				W. M. L. L. G. Deserno, M. G. Harisinghani, M. Taupitz, G. J. Jager, J. A. Witjes, P. F. Mulders, C. A. Hulsbergen van de Kaa, D. Kaufmann, and J. O. Barentsz Urinary Bladder Cancer: Preoperative Nodal Staging with Ferumoxtran-10-enhanced MR Imaging Radiology, November 1, 2004; 233(2): 449 - 456. [Abstract] [Full Text] [PDF]

				Y. Anzai, C. W. Piccoli, E. K. Outwater, W. Stanford, D. A. Bluemke, P. Nurenberg, S. Saini, K. R. Maravilla, D. E. Feldman, U. P. Schmiedl, et al. Evaluation of Neck and Body Metastases to Nodes with Ferumoxtran 10-enhanced MR Imaging: Phase III Safety and Efficacy Study Radiology, September 1, 2003; 228(3): 777 - 788. [Abstract] [Full Text] [PDF]

				V. Dousset Reply AJNR Am. J. Neuroradiol., October 1, 2000; 21(9): 1769 - 1769. [Full Text]

				M. G. Mack, J. O. Balzer, R. Straub, K. Eichler, and T. J. Vogl Superparamagnetic Iron Oxide-enhanced MR Imaging of Head and Neck Lymph Nodes Radiology, January 1, 2002; 222(1): 239 - 244. [Abstract] [Full Text] [PDF]